Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan A Stein

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Clinical Chemistry|March 16, 2012
Lipoprotein-associated phospholipase A₂ measurements: mass, activity, but little productivityEvan A Stein
Circulation|August 8, 2007
Statins and children: whom do we treat and when?Evan A Stein
Postgraduate Medicine|August 12, 2009
Future trends in the treatment of dyslipidemia. IntroductionEvan A Stein
Journal of the American College of Cardiology|December 20, 2008
Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?Evan A Stein
Postgraduate Medicine|August 12, 2009
New evidence supporting aggressive lipid loweringEvan A Stein
Current Opinion in Lipidology|November 5, 2013
Low-density lipoprotein cholesterol reduction by inhibition of PCSK9Evan A Stein
Clinical Chemistry|August 31, 2006
Are measurements of LDL particles ready for prime time?Evan A Stein
The American Journal of Managed Care|February 22, 2002
An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of careEvan A Stein
Postgraduate Medicine|August 12, 2009
Adult treatment panel III and the management of dyslipidemia risk factorsEvan A Stein
The American Journal of Cardiology|March 21, 2003
Introduction: rosuvastatin--an efficacy assessment based on pooled trial dataEvan A Stein
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Clinical Chemistry|March 16, 2012
Lipoprotein-associated phospholipase A₂ measurements: mass, activity, but little productivityEvan A Stein
Circulation|August 8, 2007
Statins and children: whom do we treat and when?Evan A Stein
Postgraduate Medicine|August 12, 2009
Future trends in the treatment of dyslipidemia. IntroductionEvan A Stein
Journal of the American College of Cardiology|December 20, 2008
Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?Evan A Stein
Postgraduate Medicine|August 12, 2009
New evidence supporting aggressive lipid loweringEvan A Stein
Current Opinion in Lipidology|November 5, 2013
Low-density lipoprotein cholesterol reduction by inhibition of PCSK9Evan A Stein
Clinical Chemistry|August 31, 2006
Are measurements of LDL particles ready for prime time?Evan A Stein
The American Journal of Managed Care|February 22, 2002
An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of careEvan A Stein
Postgraduate Medicine|August 12, 2009
Adult treatment panel III and the management of dyslipidemia risk factorsEvan A Stein
The American Journal of Cardiology|March 21, 2003
Introduction: rosuvastatin--an efficacy assessment based on pooled trial dataEvan A Stein
Pageof 12